PFIZER INC - Regulatory Approval.

PR Newswire UK Disclose, September, 2005

 
 FDA Approves Pfizer's Lipitor(R) to Reduce Risk of Strokes and Heart Attacks 
                          in Patients With Diabetes 
 
Also Approved to Reduce Stroke Risk in People with Several Other Risk Factors 
                              for Heart Disease 
 
    NEW YORK, Sept. 27 -- Pfizer Inc announced today that the U.S. Food and 
Drug Administration has approved its cholesterol-lowering medicine Lipitor(R) 
(atorvastatin calcium) to reduce the risk of stroke and heart attack in people 
with type 2 diabetes without evidence of heart disease but with other risk 
factors. Lipitor also received approval to reduce the risk of stroke in people 
without evidence of heart disease but with multiple risk factors other than 
diabetes.  Common risk factors for heart disease include...

            
        
    
    	    
                
                
	

		

					 
            Read the rest of this article with a Free Trial at HighBeam Research.
        				
 

    		            
	
                Premium Content Partnership | 
                	HighBeam Research provides an in-depth online archive library of reference works.